Reversal of cisplatin resistance in human ovarian cancer cell lines by a c-jun antisense oligodeoxynucleotide (ISIS 10582): evidence for the role of transcription factor overexpression in determining resistant phenotype (Q40732586)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Reversal of cisplatin resistance in human ovarian cancer cell lines by a c-jun antisense oligodeoxynucleotide (ISIS 10582): evidence for the role of transcription factor overexpression in determining resistant phenotype	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Reversal of cisplatin resistance in human ovarian cancer cell lines by a c-jun antisense oligodeoxynucleotide (ISIS 10582): evidence for the role of transcription factor overexpression in determining resistant phenotype (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Bin Pan

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Kang Shen Yao

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Brett P Monia

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Nicholas M Dean

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Robert A McKay

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Thomas C Hamilton

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Peter J O'Dwyer

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1699-1707

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Pi-class glutathione S-transferase: regulation and function.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Cisplatin induces a persistent activation of JNK that is related to cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Therapeutic Applications of Oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Antisense comes of age

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Do overexpressed oncoproteins cause malignant growth of cancer cells?--Studied by antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Number and distribution of methylphosphonate linkages in oligodeoxynucleotides affect exo- and endonuclease sensitivity and ability to form RNase H substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

SV40 DNA transfection of cells in suspension: analysis of the efficiency of transcription and translation of T-antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Oncogene jun encodes a sequence-specific trans-activator similar to AP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Fos and Jun: the AP-1 connection

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Jun: transcription factor and oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Induction of proto-oncogene JUN/AP-1 by serum and TPA.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Rapid and preferential activation of the c-jun gene during the mammalian UV response

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Regulation of c-fos and c-jun protooncogene expression by the Ca(2+)-ATPase inhibitor thapsigargin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Fos-associated protein p39 is the product of the jun proto-oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Induction of FOS and JUN proteins during focal epilepsy: congruences with and differences to [14C]deoxyglucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Regulation of the human chorionic gonadotropin alpha- and beta-subunit promoters by AP-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Increased c-jun/AP-1 levels in etoposide-resistant human leukemia K562 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Oncogene overexpression and de novo drug-resistance in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

ASK1 mediates apoptotic cell death induced by genotoxic stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

UV-Laser induced protein/DNA crosslinking reveals sequence variations of DNA elements bound by c-Jun in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Antioxidant response element

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Constitutive and beta-naphthoflavone-induced expression of the human gamma-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

ARE- and TRE-mediated regulation of gene expression. Response to xenobiotics and antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Chemical and molecular regulation of enzymes that detoxify carcinogens

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Functional antioxidant responsive elements.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

An electrophile responsive element (EpRE) regulates beta-naphthoflavone induction of the human gamma-glutamylcysteine synthetase regulatory subunit gene. Constitutive expression is mediated by an adjacent AP-1 site

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Control of cell cycle progression by c-Jun is p53 dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900841-9

7 January 2021

Identifiers

10.1016/S0006-2952(02)00841-9

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40732586&oldid=1906274835"